AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS
申请人:Acucela, Inc.
公开号:US20160193181A1
公开(公告)日:2016-07-07
Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
The present invention provides a method of treating a cancer associated with a K-ras mutation in a subject in need thereof. The method comprises the steps of: (1) identifying a subject with a cancer associated with a K-ras mutation; and (2) administering to the subject (i) an inhibitor of PI3 kinase and (ii) an HDAC inhibitor, wherein the PI3 kinase inhibitor and the HDAC inhibitor are administered in amounts which together are therapeutically effective.
[EN] TREATMENT OF CANCERS HAVING K-RAS MUTATIONS<br/>[FR] TRAITEMENT DE CANCERS PRÉSENTANT DES MUTATIONS K-RAS
申请人:CURIS INC
公开号:WO2011130628A1
公开(公告)日:2011-10-20
The present invention provides a method of treating a cancer associated with a K- ras mutation in a subject in need thereof. The method comprises the steps of (1) identifying a subject with a cancer associated with a K-ras mutation; and (2) adminsiterign to the subject (i) an inhibitor of PI3 kinase and (ii) an HDAC inhibitor, wherein the PI3 kinase inhibitor and the HDAC inhibitor are administered in amounts which together are therapeutically effective.
本发明提供了一种治疗与K-ras突变相关的癌症的方法,适用于需要该方法的受试者。该方法包括以下步骤:(1) 鉴定患有与K-ras突变相关的癌症的受试者;和 (2) 给予该受试者 (i) PI3激酶抑制剂和 (ii) HDAC抑制剂,其中PI3激酶抑制剂和HDAC抑制剂以治疗有效的剂量一起给予。
The present invention provides phenoxyacetic acid derivatives of Formula (I) for the treatment of CRTH2 related disorders and disease selected from asthma, atopic dermatitis and inflammatory dermatoses.
[EN] FUSED BICYCLIC COMPOUNDS AND USE THEREOF AS PI3K INHIBITORS<br/>[FR] COMPOSÉS BICYCLIQUES FUSIONNÉS ET UTILISATIONS DE CEUX-CI COMME INHIBITEURS DE P13K
申请人:MERCK SERONO SA
公开号:WO2009133127A1
公开(公告)日:2009-11-05
The invention relates to compounds of formula (I), for the regulation of phosphoinositides 3-kinases activity and related diseases.